These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1686579)

  • 21. [Acute pharmacological block of the renin-angiotensin system and the recovery of intrarenal hemodynamics in patients with chronic glomerulonephritis].
    Kutyrina IM; Tareeva IE; Zverev KV; Rogov VA
    Ter Arkh; 1993; 65(6):13-7. PubMed ID: 8378838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasodilators, antihypertensive therapy, and the kidney.
    Hollenberg NK
    Circulation; 1987 Jun; 75(6 Pt 2):V39-42. PubMed ID: 2882875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antihypertensive therapy in the presence of proteinuria.
    Sarafidis PA; Khosla N; Bakris GL
    Am J Kidney Dis; 2007 Jan; 49(1):12-26. PubMed ID: 17185142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of vasoactive therapy on cerebral circulation.
    Rhoney DH; Liu-DeRyke X
    Crit Care Clin; 2006 Apr; 22(2):221-43, vi. PubMed ID: 16677997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How much must blood pressure be reduced in order to obtain the remission of chronic renal disease?
    Pisoni R; Remuzzi G
    J Nephrol; 2000; 13(3):228-31. PubMed ID: 10928301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The functional renal reserve].
    Amiel C; Blanchet F; Friedlander G; Nitenberg A
    Nephrologie; 1991; 12(2):55-61. PubMed ID: 1944756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage.
    Perico N; Amuchastegui CS; Malanchini B; Bertani T; Remuzzi G
    Exp Nephrol; 1994; 2(4):220-8. PubMed ID: 8069658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chronotherapeutic evaluation of the antihypertensive treatment].
    Lemmer B
    Rev Esp Cardiol; 1999; 52 Suppl 3():45-52. PubMed ID: 10614149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Renal functional reserve].
    Amiel C; Blanchet F; Friedlander G; Nitenberg A
    Rev Prat; 1992 Feb; 42(4):413-6. PubMed ID: 1604158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of anti-hypertensive drugs on glomerular hemodynamics.
    Ito S; Abe K
    Nihon Jinzo Gakkai Shi; 1996 Mar; 38(3):115-8. PubMed ID: 8721331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antihypertensive drugs and renal protection.
    Fukuda M; Usami T; Yoshida A; Kimura G
    JAMA; 2003 Mar; 289(9):1102-3; author reply 1103. PubMed ID: 12622571
    [No Abstract]   [Full Text] [Related]  

  • 34. Antihypertensive therapy and renal function.
    Mimran A
    J Cardiovasc Pharmacol; 1996; 27 Suppl 3():S19-25. PubMed ID: 8872296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal consequences of antihypertensive therapy.
    Eknoyan G; Suki WN
    Semin Nephrol; 1991 Mar; 11(2):129-37. PubMed ID: 1674622
    [No Abstract]   [Full Text] [Related]  

  • 36. Lack of activation of renal functional reserve predicts the risk of significant renal involvement in systemic sclerosis.
    Livi R; Guiducci S; Perfetto F; Ciuti G; Grifoni E; Conforti L; Galluccio F; Moggi Pignone A; Matucci Cerinic M
    Ann Rheum Dis; 2011 Nov; 70(11):1963-7. PubMed ID: 21784725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The kidney and strategies for the treatment of hypertension.
    Hollenberg NK
    Am J Med; 1984 Oct; 77(4A):60-3. PubMed ID: 6207726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal functional reserve evolution in children with a previous episode of hemolytic uremic syndrome.
    Dieguez S; Ayuso S; Brindo M; Osinde E; Cánepa C
    Nephron Clin Pract; 2004; 97(3):c118-22. PubMed ID: 15292689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal functional reserve and renal recovery after acute kidney injury.
    Sharma A; Mucino MJ; Ronco C
    Nephron Clin Pract; 2014; 127(1-4):94-100. PubMed ID: 25343829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strategies in antihypertensive therapy: implications of the kidney.
    Hollenberg NK
    Am J Med; 1986 Dec; 81(6A):15-9. PubMed ID: 2879443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.